Urological Complications of Cyclophosphamide
Authors:
- 5 December 1973
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 45 (6) , 606-609
Abstract
Summary: Cyclophosphamide may cause fibrosis of the bladder in a significant number of patients. Most will be asymptomatic but the fibrosis can lead to reflux. Cystitis, frequently haemorrhagic, occurs in 10–40 % of patients and usually responds to withdrawal of the drug. Active measures to stop the bleeding may be required. Bleeding from the upper urinary tract is rare. The association of bladder tumours with cyclophosphamide cystitis has been reported in only 2 cases.Keywords
This publication has 16 references indexed in Scilit:
- Cyclophosphamide and the bladder.BMJ, 1971
- CYCLOPHOSPHAMIDE NECROSIS OF BLADDER CAUSING CALCIFICATION, CONTRACTURE AND REFLUX; TREATED BY COLOCYSTOPLASTYBritish Journal of Urology, 1971
- Multiple late complications of therapy with cyclophosphamide, including ovarian destructionThe American Journal of Medicine, 1971
- Urinary-Bladder Fibrosis and Telangiectasia Associated with Long-Term Cyclophosphamide TherapyNew England Journal of Medicine, 1971
- Treatment of Delayed Intractable Hemorrhagic Cystitis Following Radiation or ChemotherapyJournal of Urology, 1970
- Cyclophosphamide Hemorrhagic CystitisScandinavian Journal of Urology and Nephrology, 1970
- Cyclophosphamide Hemorrhagic CystitisJournal of Urology, 1967
- Metabolism of cyclophosphamideCancer, 1967
- Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in manCancer, 1964
- DISTRIBUTION OF PHOSPHAMIDASE ACTIVITY IN THE MALE ALBINO RATJournal of Histochemistry & Cytochemistry, 1957